Literature DB >> 17027294

Reliability of serum assays of iron status in postmenopausal women.

Anne Zeleniuch-Jacquotte1, Qi Zhang, Jisen Dai, Roy E Shore, Alan A Arslan, Karen L Koenig, Jerzy Karkoszka, Yelena Afanasyeva, Krystyna Frenkel, Paolo Toniolo, Xi Huang.   

Abstract

PURPOSE: The aim of the study is to determine the reliability during a 2-year period of several newly developed iron-related assays to assess their potential for use in prospective epidemiologic studies.
METHODS: We assessed the temporal reliability of several iron-related assays by using three serum samples collected at yearly intervals from 50 postmenopausal participants in a large prospective study.
RESULTS: We observed high reliability coefficients for ferritin (0.78; 95% confidence interval [CI], 0.67-0.86), soluble transferrin receptor (sTfR; 0.79; 95% CI, 0.69-0.87), sTfR/ferritin ratio (0.74; 95% CI, 0.62-0.83), and hepcidin (0.89; 95% CI, 0.84-0.94). In a subset of 30 women, lower reliability was observed for serum iron (0.50; 95% CI, 0.29-0.70), unsaturated iron-binding capacity (0.55; 95% CI, 0.34-0.73), total iron-binding capacity (0.60; 95% CI, 0.40-0.76), and serum transferrin saturation rate (0.44; 95% CI, 0.22-0.65). The reliability of anti-5-hydroxymethyl-2'-deoxyuridine autoantibody titers, a biomarker of oxidized DNA damage, one of the mechanisms by which iron is thought to impact disease risk, was very high (0.97, 95% CI, 0.5-0.99).
CONCLUSIONS: Our results show that some newly developed iron-related assays could be useful tools to assess iron-disease associations in prospective cohorts that collect a single blood sample.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17027294      PMCID: PMC2965063          DOI: 10.1016/j.annepidem.2006.07.004

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  38 in total

1.  Endogenous hormones and breast cancer: a prospective cohort study.

Authors:  P G Toniolo; B S Pasternack; R E Shore; E Sonnenschein; K L Koenig; C Rosenberg; P Strax; S Strax
Journal:  Breast Cancer Res Treat       Date:  1991-05       Impact factor: 4.872

2.  Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.

Authors:  S E Hankinson; W C Willett; J E Manson; G A Colditz; D J Hunter; D Spiegelman; R L Barbieri; F E Speizer
Journal:  J Natl Cancer Inst       Date:  1998-09-02       Impact factor: 13.506

Review 3.  The laboratory assessment of iron status--an update.

Authors:  M Worwood
Journal:  Clin Chim Acta       Date:  1997-03-18       Impact factor: 3.786

4.  Recognition of oxidized DNA bases by sera of patients with inflammatory diseases.

Authors:  K Frenkel; J Karkoszka; E Kim; E Taioli
Journal:  Free Radic Biol Med       Date:  1993-05       Impact factor: 7.376

5.  Iron supplement use and iron status among US adults: results from the third National Health and Nutrition Examination Survey.

Authors:  Heidi Michels Blanck; Mary E Cogswell; Cathleen Gillespie; Michele Reyes
Journal:  Am J Clin Nutr       Date:  2005-11       Impact factor: 7.045

6.  Iron, lipids, and risk of cancer in the Framingham Offspring cohort.

Authors:  Arch G Mainous; Brian J Wells; Richelle J Koopman; Charles J Everett; James M Gill
Journal:  Am J Epidemiol       Date:  2005-06-15       Impact factor: 4.897

7.  Impact of menstrual blood loss and diet on iron deficiency among women in the UK.

Authors:  Linda J Harvey; Charlotte N Armah; Jack R Dainty; Robert J Foxall; D John Lewis; Nicola J Langford; Susan J Fairweather-Tait
Journal:  Br J Nutr       Date:  2005-10       Impact factor: 3.718

8.  Serum autoantibodies recognizing 5-hydroxymethyl-2'-deoxyuridine, an oxidized DNA base, as biomarkers of cancer risk in women.

Authors:  K Frenkel; J Karkoszka; T Glassman; N Dubin; P Toniolo; E Taioli; L A Mooney; I Kato
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-01       Impact factor: 4.254

9.  Dietary determinants of iron stores in a free-living elderly population: The Framingham Heart Study.

Authors:  D J Fleming; P F Jacques; G E Dallal; K L Tucker; P W Wilson; R J Wood
Journal:  Am J Clin Nutr       Date:  1998-04       Impact factor: 7.045

10.  Serum transferrin receptor: a quantitative measure of tissue iron deficiency.

Authors:  B S Skikne; C H Flowers; J D Cook
Journal:  Blood       Date:  1990-05-01       Impact factor: 22.113

View more
  6 in total

1.  17β-Estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-site.

Authors:  Qing Yang; Jinlong Jian; Stuart Katz; Steven B Abramson; Xi Huang
Journal:  Endocrinology       Date:  2012-04-25       Impact factor: 4.736

2.  Circulating biomarkers of iron storage and clearance of incident human papillomavirus infection.

Authors:  Erin M Siegel; Nitin Patel; Beibei Lu; Ji-Hyun Lee; Alan G Nyitray; Xi Huang; Luisa L Villa; Eduardo L Franco; Anna R Giuliano
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-03-16       Impact factor: 4.254

3.  Brain structure in healthy adults is related to serum transferrin and the H63D polymorphism in the HFE gene.

Authors:  Neda Jahanshad; Omid Kohannim; Derrek P Hibar; Jason L Stein; Katie L McMahon; Greig I de Zubicaray; Sarah E Medland; Grant W Montgomery; John B Whitfield; Nicholas G Martin; Margaret J Wright; Arthur W Toga; Paul M Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-09       Impact factor: 11.205

4.  Serum prohepcidin is associated with soluble transferrin receptor-1 but not ferritin in healthy post-menopausal women.

Authors:  Xi Huang; Eric T Fung; Christine Yip; Anne Zeleniuch-Jacquotte
Journal:  Blood Cells Mol Dis       Date:  2008-08-09       Impact factor: 3.039

5.  Reliability of tumor markers, chemokines, and metastasis-related molecules in serum.

Authors:  Faina Linkov; Yian Gu; Alan A Arslan; Mengling Liu; Roy E Shore; Lyudmila Velikokhatnaya; Karen L Koenig; Paolo Toniolo; Adele Marrangoni; Zoya Yurkovetsky; Anne Zeleniuch-Jacquotte; Anna E Lokshin
Journal:  Eur Cytokine Netw       Date:  2009-03       Impact factor: 2.737

6.  Age-dependent ferritin elevations and HFE C282Y mutation as risk factors for symptomatic knee osteoarthritis in males: a longitudinal cohort study.

Authors:  Lauren Kennish; Mukundan Attur; Cheongeun Oh; Svetlana Krasnokutsky; Jonathan Samuels; Jeffrey D Greenberg; Xi Huang; Steven B Abramson
Journal:  BMC Musculoskelet Disord       Date:  2014-01-08       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.